A Study to Evaluate the Safety of Adjuvant Treatment With Exemestane Following Previous Treatment With Tamoxifen in Postmenopausal Women With Estrogen Sensitive Primary Breast Cancer

Clinical trial NCT00649090 · COMPLETED

Trial details

NCT number: NCT00649090
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2005-03-01
Primary completion: 2007-04-01
Enrollment: 1549

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.